Actions of serotonergic agents on hypothalamic-pituitary-adrenal axis activity in the rat

General Pharmacology

Volumn 29, Issue 5, 1997, Pages 823-828

  Matheson, G Keith ^a   Knowles, Andrew ^a   Guthrie, Deanne ^a   Gage, Deanna ^a   Weinzapfel, Dan ^a   Blackbourne, Jamie ^a  

^a Indiana University School of Medicine Evansville   (United States)

Author keywords

Anxiolytics; BMS 20661; Buspirone; Corticosterone; Dexamethasone; Gepirone; Ipsapirone; Nefazodone; Serotonin; Stress; Tiasipirone

Indexed keywords

BMS 20661; BUSPIRONE; GEPIRONE; IPSAPIRONE; NEFAZODONE; TIOSPIRONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DECAPITATION; DOSE RESPONSE; DRUG EFFECT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CIRCADIAN RHYTHM; CORTICOSTERONE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RATS; SEROTONIN AGENTS; STRESS, PSYCHOLOGICAL;

EID: 0030667754     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00006-2     Document Type: Article

References (37)

1. Akiyoshi J., Tsuchiyama K., Yamada K., Oba A., Yamada K., Kojima K., Sasaki I. and Nagayama H. (1995) Effects of 8-OH-DPAT on corticosterone after acute and chronic administration of antidepressants. Prog. Neuro-Psychopharmac. Biol. Psychiatry 19, 93-103.
2. 1 agonists in rat. Neuroendocrinology 50, 241-247.
3. Biegon A., Rainbow T. C. and McEwen B. S. (1985) Corticosterone modulation of neurotransmitter receptors in rat hippocampus: a quantitative autoradiographic study. Brain Res. 332, 309-314.
4. Carroll B. J., Curtis G. C., and Mendels J. (1976) Neuroendocrine regulation in depression, I: limbic system-adrenocortical dysfunction. Arch. Gen. Psychiatry 33, 1039-1044.
5. Chaouloff F. (1995) Regulation of 5-HT receptors by corticosteroids: where do we stand? Fundam. Clin. Pharmac. 9, 219-233.
6. Cusack B., Nelson A. and Richelson E. (1994) Binding of antidepressants to human brain receptors: focus on newer generation of compounds. Psychopharmacology 114, 559-565.
7. de Kloet R., Wallach G. and McEwen B. S. (1975) Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 96, 598-609.
8. 3H]TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic. Naunyn-Schmiedeberg's Arch. Pharmac. 328, 467-470.
9. Eison A. S., Eison M. S., Torrente J. R., Wright R. N. and Yocca F. D. (1990) Nefazodone: preclinical pharmacology of a new antidepressant. Psychopharmac. Bull. 26, 311-315.
10. Fuller R. W. (1981) Serotonergic stimulation of pituitary-adrenocortical function in rats. Neuroendocrinology 32, 118-127.
11. Fuller R. W. (1992) The involvement of serotonin in regulation of pituitary-adrenocortical function. Front. Neuroendocrinol. 13, 250-270.
12. Fuxe K., Wikström A.-C., Okret S., Agnati L. F., Harfstrand A., Yu Z.-Y., Granholm L., Zoli M., Vale W. and Gustafsson J.-A. (1985) Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel-and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 117, 1803-1812.
13. 1A receptor subtype increases rat plasma ACTH concentration. Eur. J. Pharmac. 147, 431-439.
14. Glaser T., Rath M., Traber J., Zilles K. and Schleicher A. (1985) Autoradiographic identification and topographical analyses of high affinity serotonin receptor subtypes as a target for the novel putative anxiolytic TVXQ 7821. Brain Res. 358, 129-136.
15. Glick D., von Redlich D. and Levine S. (1964) Fluotometric determination of corticosterone and cortisol in 0.02-0.05 milliliters of plasma or sub-milligram samples of adrenal tissue. Endocrinology 74, 653-655.
16. Haleem D. J. (1992) Repeated corticosterone treatment attenuates behavioral and neuroendocrine responses to 8-hydroxy-2-(di-n-propylamino)-tetralin in rats. Life Sci. 51, PL225-230.
17. 1A receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmac. Biochem. Behav. 29, 711-715.
18. Kovács K. and Makara G. (1988) Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adrenocorticotropin hypersecretion. Brain Res. 474, 205-210.
19. 1A receptor responsivity in unipolar depression: evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biol. Psychiatry 28, 620-628.
20. 2) agonists and antagonists on renin and corticosterone secretion. Neuroendocrinology 45, 305-310.
21. Maes M., Meltzer H. Y., D'Hondt P., Cosyns P. and Blockx P. (1995) Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psychoneuroendocrinology 20, 149-167.
22. Matheson G. K., Gage D., White G., Dixon V. and Gipson D. (1988) A comparison of the effects of buspirone and diazepam on plasma corticosterone levels in rat. Neuropharmacology 27, 823-830.
23. Matheson G. K., Gage-White D., White G., Guthrie D., Rhoades J. and Dixon V. (1989) The effect of gepirone and 1-(2-pyrimidinyl)-piperazine on levels of corticosterone in rat plasma. Neuropharmacology 28, 329-334.
24. 1A neurons of the dorsal raphe. Gen. Pharmac. 25, 675-683.
25. 3H]buspirone binding in rat brain by autoradiography. In Buspirone: Mechanisms and Clinical Aspects. (Edited by Tunnicliff G., Eison A. S. and Taylor D. P.) pp. 139-148. Academic Press, San Diego.
26. McMillen B. A. (1985) Acute and subchronic effects of MJ-13859, a potential antipsychotic drug, on rat brain dopaminergic function. J. Pharmac. Exp. Ther. 233, 369-375.
27. Nakagami Y., Suda T., Yajima F. Ushiyama T., Tomori N., Sumitomo T., Demura H., and Shizume K. (1986) Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from rat hypothalamus in vitro. Brain Res. 386, 232-236.
28. Pazos A. and Palacios J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain I: serotonin-1 receptors. Brain Res. 346, 205-230.
29. 1A receptors. Biol. Psychiatry 20, 971-979.
30. Reul J. M. H. M. and de Kloet E. R. (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117, 2505-2511.
31. Robinson D. S., Alms D. R., Shrotriya R. C., Messina M. and Wickramaratne P. (1989) Serotonergic anxiolytics and treatment of depression. Psychopathology 22(Suppl. 1), 27-36.
32. 1A receptor activation by flesinoxan in humans: body temperature and neuroendocrine responses. Neuropsychopharmacology 13, 93-104.
33. 1A selective drugs on the 5-HT behavioral syndrome. Pharmac. Biochem. Behav. 24, 1513-1519.
34. Taylor D. P., New J. S., Eison M. S., Hyslop D. K., Butler R., Allen L. E., Yocca F. D., VanderMaelen C. P. and Yevich J. P. (1987) BMY 20661: potential antipsychotic agent that does not bind to D-2 dopamine sites. Soc. Neurosci. Abstr. 13, 457.
35. Van de Kar L. D. (1991) Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu. Rev. Pharmac. Toxicol. 31, 289-320.
36. VanderMaelen C. P., Taylor D. P., Gehlbach G. and Eison M. S. (1986) Nonbenzodiazepine anxiolytics: insights into possible mechanisms of action. Psychopharmac. Bull. 22, 807-812.
37. 1A receptors inhibit adrenocortical secretion. Neuroendocrinology 57, 272-281.